We are live on
!
Find out more
CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
44 hedge funds and large institutions have $18.9M invested in CASI Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
0.33% less ownership
Funds ownership: 2% → 1.67% (-0.33%)
14% less funds holding
Funds holding: 51 → 44 (-7)
16% less capital invested
Capital invested by funds: $22.4M → $18.9M (-$3.48M)
60% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 10
64% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 14
Holders
44
Holders Change
-7
Holders Change %
-13.73%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
14
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
WSC
Wellington Shields & Co
New York
|
+$245K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$106K |
| 3 |
IC
Ikarian Capital
Dallas,
Texas
|
+$76.3K |
| 4 |
Citigroup
New York
|
+$57.4K |
| 5 |
VF
Virtu Financial
New York
|
+$25.1K |
Top Sellers
| 1 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.34M |
| 2 |
Renaissance Technologies
New York
|
-$1.02M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$620K |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$241K |
| 5 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$214K |
